All Relations between asymmetrical (pato 0000616) and nitrogen monoxide

Reference Sentence Publish Date Extraction Date Species
Ebru Doneray, Kemal Utku Yazici, Ipek Percinel Yazici, Bilal Ustunda. Altered Arginine/Nitric Oxide Pathway in Children Diagnosed Attention Deficit Hyperactivity Disorder, and the Effect of 10 Weeks Methylphenidate Treatment. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology vol 20 issue 2 2022 35466106 in this study, we investigated the levels of arginine, nitric oxide (no), asymmetric dimethylarginine (adma), and adrenomedullin that are presumed to play a role in attention deficit hyperactivity disorder (adhd) etiology, and to compare the findings with healthy controls. 2022-04-25 2022-04-26 Not clear
Mingyue Zhao, Xin Liu, Yuzhu Hou, Tongtong Yang, Jiaquan Xu, Rui S. Combination of Electrochemistry and Mass Spectrometry to Study Nitric Oxide Metabolism and Its Modulation by Compound K in Breast Cancer Cells. Analytical chemistry vol issue 2022 35306816 the levels of l-arginine and asymmetric dimethylarginine (adma) and the amount of the nitric oxide (no) production have recently been linked to breast cancer and pharmaceutical effect evaluation. 2022-03-21 2022-04-14 Not clear
Juliane Hannemann, Julia Zummack, Jonas Hillig, Leonard Rendant-Gantzberg, Rainer B\\xc3\\xb6ge. Association of Variability in the DDAH1, DDAH2, AGXT2 and PRMT1 Genes with Circulating ADMA Concentration in Human Whole Blood. Journal of clinical medicine vol 11 issue 4 2022 35207213 asymmetric dimethylarginine is an endogenous inhibitor of nitric oxide synthesis and a cardiovascular risk factor. 2022-02-25 2022-02-27 Not clear
Eslam E Elhawary, Seham F Khedr, Hala M Nagy, Mohamed H El-Bradey, Mohamed R Elshanshor. Correlation of Asymmetric Dimethyl Arginine Level to Sickle Retinopathy in Children With Sickle Cell Disease. Journal of pediatric hematology/oncology vol issue 2022 35180766 asymmetric dimethyl arginine (adma) is a competitive inhibitor of nitric oxide synthetase especially in l-arginine deficiency, which is the case in sickle cell disease (scd). 2022-02-18 2022-02-23 Not clear
Marius Marc-Daniel Mader, Patrick Czorlic. The role of L-arginine metabolism in neurocritical care patients. Neural regeneration research vol 17 issue 7 2021 34916417 asymmetric dimethylarginine is an endogenous inhibitor of nitric oxide synthase and can lead to endothelial dysfunction. 2022-02-04 2022-01-13 Not clear
Angelo Zinellu, Arduino A Mangon. An updated systematic review and meta-analysis of the effect of statins on asymmetric dimethylarginine. Nitric oxide : biology and chemistry vol issue 2022 35032642 we conducted an updated systematic review and meta-analysis of the effect of statins on serum or plasma concentrations of the endogenous inhibitor of endothelial nitric oxide synthase, asymmetric n 2022-02-01 2022-01-27 Not clear
Angelo Zinellu, Arduino A Mangon. An updated systematic review and meta-analysis of the effect of statins on asymmetric dimethylarginine. Nitric oxide : biology and chemistry vol issue 2022 35032642 we conducted an updated systematic review and meta-analysis of the effect of statins on serum or plasma concentrations of the endogenous inhibitor of endothelial nitric oxide synthase, asymmetric n 2022-01-15 2022-01-27 Not clear
Juliane Hannemann, Patricia Siques, Lena Schmidt-Hutten, Julia Zummack, Julio Brito, Rainer B\\xc3\\xb6ge. Association of Genes of the NO Pathway with Altitude Disease and Hypoxic Pulmonary Hypertension. Journal of clinical medicine vol 10 issue 24 2021 34945057 chronic intermittent hypoxia leads to high-altitude pulmonary hypertension, which is associated with high asymmetric dimethylarginine (adma), an endogenous inhibitor of nitric oxide synthesis. 2021-12-24 2022-01-13 Not clear
Marius Marc-Daniel Mader, Patrick Czorlic. The role of L-arginine metabolism in neurocritical care patients. Neural regeneration research vol 17 issue 7 2021 34916417 asymmetric dimethylarginine is an endogenous inhibitor of nitric oxide synthase and can lead to endothelial dysfunction. 2021-12-17 2022-01-13 Not clear
Vijay Raj, Suganya Natarajan, Marimuthu C, Suvro Chatterjee, Mohankumar Ramasamy, Ganesh Munuswamy Ramanujam, Mariadhas Valan Arasu, Naif Abdullah Al-Dhabi, Ki Choon Choi, Jesu Arockiaraj, Kanchana Karuppia. Cholecalciferol and metformin protect against lipopolysaccharide-induced endothelial dysfunction and senescence by modulating sirtuin-1 and protein arginine methyltransferase-1. European journal of pharmacology vol 912 issue 2021 34710370 we found that lps challenge (i) increased arginine methylation through up-regulated protein arginine methyltransferase-1 (prmt1) mrna, intracellular concentrations of asymmetric dimethylarginine (adma) and homocysteine (hcy); (ii) up-regulated cell senescence through mitigated sirtuin-1 (sirt1) mrna, nicotinamide adenine dinucleotide (nad+) concentration, telomerase activity and total antioxidant capacity; and (iii) lead to endothelial dysfunction through compromised nitric oxide (nox) production. 2021-11-22 2022-01-13 Not clear
Pratishtha Chatterjee, Yeo-Jin Cheong, Atul Bhatnagar, Kathryn Goozee, Yunqi Wu, Matthew McKay, Ian J Martins, Wei L F Lim, Steve Pedrini, Michelle Tegg, Victor L Villemagne, Prita R Asih, Preeti Dave, Tejal M Shah, Cintia B Dias, Stephanie J Fuller, Heidi Hillebrandt, Sunil Gupta, Eugene Hone, Kevin Taddei, Henrik Zetterberg, Kaj Blennow, Hamid R Sohrabi, Ralph N Martin. Plasma metabolites associated with biomarker evidence of neurodegeneration in cognitively normal older adults. Journal of neurochemistry vol 159 issue 2 2021 32679614 metabolites belonging to biogenic amine (creatinine, symmetric dimethylarginine, asymmetric dimethylarginine; adma, kynurenine, trans-4-hydroxyproline), amino acid (citrulline, proline, arginine, asparagine, phenylalanine, threonine) and acylcarnitine classes were observed to have positive correlations with plasma nf-l, suggesting a link between neurodegeneration and biological pathways associated with neurotransmitter regulation, nitric oxide homoeostasis, inflammation and mitochondrial function. 2021-11-19 2022-01-13 Not clear
Jung-Hoon Pyun, Byeong-Yun Ahn, Tuan Anh Vuong, Su Woo Kim, Yunju Jo, Jaehyung Jeon, Seung Ho Baek, Jaewon Kim, Sungsu Park, Gyu-Un Bae, Jun-Hyuk Choi, Jae-Ryong Kim, Dongryeol Ryu, Sang-Jin Lee, Jong-Sun Kan. Inducible Prmt1 ablation in adult vascular smooth muscle leads to contractile dysfunction and aortic dissection. Experimental & molecular medicine vol 53 issue 10 2021 34635781 protein arginine methyltransferase 1 (prmt1) is a major enzyme catalyzing asymmetric arginine dimethylation of proteins that are sources of asymmetric dimethylarginine (adma), an endogenous inhibitor of nitric oxide synthase. 2021-11-18 2022-01-13 Not clear
Neveen Tawfik Abed, Omima Mohamed Abdel Haie, Amira Ibrahim Mansour, Eman Rateb Abd Almonae. Relation of asymmetric dimethylarginine with pulmonary morbidities in neonatal respiratory distress syndrome. Journal of neonatal-perinatal medicine vol 14 issue 4 2021 33646184 asymmetric dimethyl arginine (adma) is an endogenous inhibitor of nitric oxide synthase (nos) is important in different diseases characterized by decreased nitric oxide (no) availability. 2021-11-15 2022-01-13 Not clear
Inderjit Singh, Judong Kim, Nishant Saxena, Seungho Choi, S M Touhidul Islam, Avtar K Singh, Mushfiquddin Khan, Jeseong Wo. Vascular and immunopathological role of Asymmetric Dimethylarginine (ADMA) in Experimental Autoimmune Encephalomyelitis. Immunology vol 164 issue 3 2021 34310708 asymmetric dimethylarginine (adma) is an endogenous nitric oxide synthase (nos) inhibitor/uncoupler inducing vascular pathology. 2021-11-12 2022-01-13 Not clear
Guo-Hua Ni, Jin-Fang Cheng, Yuan-Jian Li, Qi-Ying Xie, Tian-Lun Yang, Mei-Fang Che. Effect of profilin-1 on the asymmetric dimethylarginine-induced vascular lesion-associated hypertension. The Kaohsiung journal of medical sciences vol issue 2021 34741409 previous studies have demonstrated that the levels of asymmetric dimethylarginine (adma), an endogenous inhibitor of nitric oxide (no) synthesis, are strongly associated with hypertension, diabetes, and cardiovascular diseases. 2021-11-06 2022-01-13 Not clear
Ibrahim Musa Yola, Carlee Moser, Meredith S Duncan, Edzard Schwedhelm, Dorothee Atzler, Renke Maas, Juliane Hannemann, Rainer H B\\xc3\\xb6ger, Ramachandran S Vasan, Vanessa Xanthaki. Associations of circulating dimethylarginines with the metabolic syndrome in the Framingham Offspring study. PloS one vol 16 issue 9 2021 34492019 circulating levels of the endogenous inhibitor of nitric oxide synthase, asymmetric dimethylarginine (adma), are positively associated with the prevalence of metabolic syndrome (mets) in cross-sectional investigations. 2021-11-05 2022-01-13 Not clear
Paulina Guerrero-Almaraz, Manuel Quiroz, Joseph H Reibenspies, Marcetta Y Darensbour. Linear and Bent Nitric Oxide Ligand Binding in an Asymmetric Butterfly Complex: Inorganic chemistry vol 60 issue 21 2021 34157221 linear and bent nitric oxide ligand binding in an asymmetric butterfly complex: two synthetic approaches to install metallodithiolate ligands on molybdenum centers using the synthons [mo 2021-11-02 2022-01-13 Not clear
Chien-Ning Hsu, You-Lin Tai. Asymmetric Dimethylarginine (ADMA) in Pediatric Renal Diseases: From Pathophysiological Phenomenon to Clinical Biomarker and Beyond. Children (Basel, Switzerland) vol 8 issue 10 2021 34682102 asymmetric dimethylarginine (adma), an endogenous nitric oxide (no) synthase inhibitor, inhibits no synthesis and contributes to the pathogenesis of many human diseases. 2021-10-26 2022-01-13 Not clear
Fady Azmy Kyrillos, Mohamad Motawea, Mohamed Abd-El-Aziz, Azza Al-Bayoumy, Talal Amer, Mamdouh El-Naha. Plasma levels of Asymmetric Di Methyl Arginine and endothelial dysfunction in diabetic subjects with neuropathic foot ulcer. Foot (Edinburgh, Scotland) vol 48 issue 2021 34388426 asymmetric dimethyl arginine (adma) is an amino acid that acts as an endogenous competitive inhibitor of nitric oxide synthase, leading to endothelial dysfunction (ed). 2021-10-25 2022-01-13 Not clear
Irakli Kopaliani, Natalia Jarzebska, Silke Billoff, Anne Kolouschek, Jens Martens-Lobenhoffer, Stefan R Bornstein, Stefanie M Bode-B\\xc3\\xb6ger, Vinitha N Ragavan, Norbert Weiss, Arduino A Mangoni, Andreas Deussen, Roman N Rodiono. Overexpression of dimethylarginine dimethylaminohydrolase 1 protects from angiotensin II-induced cardiac hypertrophy and vascular remodeling. American journal of physiology. Heart and circulatory physiology vol 321 issue 5 2021 34533401 cardiovascular complications are the leading cause of death, and elevated levels of asymmetric dimethyarginine (adma), an endogenous inhibitor of nitric oxide synthase, are implicated in their pathophysiology. 2021-10-25 2022-01-14 Not clear
Page: 
1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35   36   37   38   39   40   41   42   43   44   45   46   47   48   49   50   51   52   53   54